Abstract

An explosion of knowledge on the molecular and cellular mechanisms that mediate carcinogenesis has occurred in recent years. Although cancer has existed for over a million years in the human species, effective cures for most cancers that target molecular and cellular pathways have not been achieved. Multiple cellular targets have been examined for preventing or treating cancers including, but not limited to, transcription factors, kinase-mediated cell signaling pathways, and more recently epigenetic targeting of oncogenes and tumor suppressors, and immunomodulation such as chimeric antigen receptor-T cells. Even as the state of knowledge of cancer mechanisms increases, there is considerable room for improvement in preventing and treating cancers. Understanding how a normal cell is transformed into a cancer cell is known but there is considerable tissue and cell type specificity. This has given rise to the field of precision medicine as applied to cancer therapy. Thus, while the development of preventive and treatment regimens has increased, there are certain obstacles that need to be overcome in order to decrease cancer incidence and increase survival of cancer patients. The purpose of this review is to summarize the advances made in cancer biology and how these advances have been used to develop, and hinder, preventive, and therapeutic strategies for cancer.

Original languageEnglish (US)
Pages (from-to)277-283
Number of pages7
JournalToxicological Sciences
Volume165
Issue number2
DOIs
StatePublished - Oct 1 2018

Fingerprint

Cell signaling
T-Cell Antigen Receptor
Medicine
Explosions
Tumors
Carcinogenesis
Transcription Factors
Phosphotransferases
Cells
Tissue
Neoplasms
Precision Medicine
Organ Specificity
Immunomodulation
Oncogenes
Epigenomics

All Science Journal Classification (ASJC) codes

  • Toxicology

Cite this

@article{ab8c8a037e304c2a97b7feee5e5ca72d,
title = "Molecular Regulation of Carcinogenesis: Friend and Foe",
abstract = "An explosion of knowledge on the molecular and cellular mechanisms that mediate carcinogenesis has occurred in recent years. Although cancer has existed for over a million years in the human species, effective cures for most cancers that target molecular and cellular pathways have not been achieved. Multiple cellular targets have been examined for preventing or treating cancers including, but not limited to, transcription factors, kinase-mediated cell signaling pathways, and more recently epigenetic targeting of oncogenes and tumor suppressors, and immunomodulation such as chimeric antigen receptor-T cells. Even as the state of knowledge of cancer mechanisms increases, there is considerable room for improvement in preventing and treating cancers. Understanding how a normal cell is transformed into a cancer cell is known but there is considerable tissue and cell type specificity. This has given rise to the field of precision medicine as applied to cancer therapy. Thus, while the development of preventive and treatment regimens has increased, there are certain obstacles that need to be overcome in order to decrease cancer incidence and increase survival of cancer patients. The purpose of this review is to summarize the advances made in cancer biology and how these advances have been used to develop, and hinder, preventive, and therapeutic strategies for cancer.",
author = "Patterson, {Andrew D.} and Gonzalez, {Frank J.} and Perdew, {Gary H.} and Peters, {Jeffrey M.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1093/toxsci/kfy185",
language = "English (US)",
volume = "165",
pages = "277--283",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "2",

}

Molecular Regulation of Carcinogenesis : Friend and Foe. / Patterson, Andrew D.; Gonzalez, Frank J.; Perdew, Gary H.; Peters, Jeffrey M.

In: Toxicological Sciences, Vol. 165, No. 2, 01.10.2018, p. 277-283.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Molecular Regulation of Carcinogenesis

T2 - Friend and Foe

AU - Patterson, Andrew D.

AU - Gonzalez, Frank J.

AU - Perdew, Gary H.

AU - Peters, Jeffrey M.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - An explosion of knowledge on the molecular and cellular mechanisms that mediate carcinogenesis has occurred in recent years. Although cancer has existed for over a million years in the human species, effective cures for most cancers that target molecular and cellular pathways have not been achieved. Multiple cellular targets have been examined for preventing or treating cancers including, but not limited to, transcription factors, kinase-mediated cell signaling pathways, and more recently epigenetic targeting of oncogenes and tumor suppressors, and immunomodulation such as chimeric antigen receptor-T cells. Even as the state of knowledge of cancer mechanisms increases, there is considerable room for improvement in preventing and treating cancers. Understanding how a normal cell is transformed into a cancer cell is known but there is considerable tissue and cell type specificity. This has given rise to the field of precision medicine as applied to cancer therapy. Thus, while the development of preventive and treatment regimens has increased, there are certain obstacles that need to be overcome in order to decrease cancer incidence and increase survival of cancer patients. The purpose of this review is to summarize the advances made in cancer biology and how these advances have been used to develop, and hinder, preventive, and therapeutic strategies for cancer.

AB - An explosion of knowledge on the molecular and cellular mechanisms that mediate carcinogenesis has occurred in recent years. Although cancer has existed for over a million years in the human species, effective cures for most cancers that target molecular and cellular pathways have not been achieved. Multiple cellular targets have been examined for preventing or treating cancers including, but not limited to, transcription factors, kinase-mediated cell signaling pathways, and more recently epigenetic targeting of oncogenes and tumor suppressors, and immunomodulation such as chimeric antigen receptor-T cells. Even as the state of knowledge of cancer mechanisms increases, there is considerable room for improvement in preventing and treating cancers. Understanding how a normal cell is transformed into a cancer cell is known but there is considerable tissue and cell type specificity. This has given rise to the field of precision medicine as applied to cancer therapy. Thus, while the development of preventive and treatment regimens has increased, there are certain obstacles that need to be overcome in order to decrease cancer incidence and increase survival of cancer patients. The purpose of this review is to summarize the advances made in cancer biology and how these advances have been used to develop, and hinder, preventive, and therapeutic strategies for cancer.

UR - http://www.scopus.com/inward/record.url?scp=85054084168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054084168&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfy185

DO - 10.1093/toxsci/kfy185

M3 - Review article

C2 - 30053205

AN - SCOPUS:85054084168

VL - 165

SP - 277

EP - 283

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 2

ER -